Unknown

Dataset Information

0

Anti-CD45RB Antibody Therapy Attenuates Renal Ischemia-Reperfusion Injury by Inducing Regulatory B Cells.


ABSTRACT: BACKGROUND:Regulatory B cells are a newly discovered B cell subset that suppresses immune responses. Recent studies found that both anti-CD45RB and anti-Tim-1 treatments regulate immune responses by inducing regulatory B cells; however, the role of these cells in renal ischemia-reperfusion injury (IRI) is unknown. METHODS:Using mouse models, including T cell-deficient (RAG1 knockout and TCR? knockout) mice and B cell-deficient (?MT) mice, we investigated the effects of regulatory B cells and anti-CD45RB on IRI and the mechanisms underlying these effects. RESULTS:Adoptive transfer of regulatory B cells before or after IRI attenuated renal IRI. Anti-CD45RB treatment with or without anti-Tim-1 before IRI increased renal infiltration of CD19+Tim-1+ regulatory B and regulatory T cells. Anti-CD45RB decreased serum creatinine levels, pathologic injury score, tubular apoptosis, and proinflammatory cytokines levels, whereas IL-10 levels increased. Following IRI, anti-CD45RB with or without anti-Tim-1 also induced regulatory B cells, improving renal function and tubular regeneration. In RAG1 knockout mice with B cell transfer, TCR? knockout mice, and wild-type mice with T cell depletion, anti-CD45RB increased regulatory B cells and attenuated IRI. However, anti-CD45RB did not attenuate IRI in RAG1 knockout mice with T cell transfer or ?MT mice and induced only mild improvement in wild-type mice with B cell depletion. Furthermore, B cell-deficient mice receiving B cells from IL-10 knockout mice (but not from wild-type mice) did not show renal protection against IRI when treated with anti-CD45RB. CONCLUSIONS:Anti-CD45RB treatment attenuated acute renal injury and facilitated renal recovery after IRI through induction of IL-10+ regulatory B cells, pointing to anti-CD45RB as a potential therapeutic strategy in renal IRI.

SUBMITTER: Fang T 

PROVIDER: S-EPMC6779371 | biostudies-literature | 2019 Oct

REPOSITORIES: biostudies-literature

altmetric image

Publications

Anti-CD45RB Antibody Therapy Attenuates Renal Ischemia-Reperfusion Injury by Inducing Regulatory B Cells.

Fang Taishi T   Koo Tai Yeon TY   Lee Jae-Ghi JG   Jang Joon Young JY   Xu Yixuan Y   Hwang Ju Hee JH   Park Sunjoo S   Yan Ji-Jing JJ   Ryu Jung-Hwa JH   Ryu Yeon-Mi YM   Kim Sang-Yeob SY   Suh Kyung-Suk KS   Yang Jaeseok J  

Journal of the American Society of Nephrology : JASN 20190711 10


<h4>Background</h4>Regulatory B cells are a newly discovered B cell subset that suppresses immune responses. Recent studies found that both anti-CD45RB and anti-Tim-1 treatments regulate immune responses by inducing regulatory B cells; however, the role of these cells in renal ischemia-reperfusion injury (IRI) is unknown.<h4>Methods</h4>Using mouse models, including T cell-deficient (RAG1 knockout and TCR<i>α</i> knockout) mice and B cell-deficient (<i>μ</i>MT) mice, we investigated the effects  ...[more]

Similar Datasets

| S-EPMC3785269 | biostudies-literature
| S-EPMC2573003 | biostudies-literature
2023-03-11 | PXD029723 | Pride
2021-11-13 | GSE188628 | GEO
| S-EPMC8548467 | biostudies-literature
| S-EPMC5300190 | biostudies-literature
| S-EPMC5167622 | biostudies-literature